Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy
β Scribed by P. Schrenk
- Publisher
- Blackwell Publishing
- Year
- 2005
- Tongue
- German
- Weight
- 68 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0001-544X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Axillary lymph node dissection for staging the axilla in breast carcinoma patients is associated with considerable morbidity, such as edema of the arm, pain, sensory disturbances, impairment of arm mobility, and shoulder stiffness. Sentinel lymph node biopsy electively removes the first lymph node,
## Background: There are no data available from randomized controlled trials that compare the efficacy of sentinel lymph node (sln) biopsy with level i/ii axillary lymph node dissection (alnd) in patients with breast carcinoma. we performed a formal decision analysis to determine whether sln biopsy